Skip to main content
Premium Trial:

Request an Annual Quote

Mayo, India Sign Research Pact

NEW YORK (GenomeWeb News) – Mayo Clinic and the Indian government have inked a memorandum of understanding to work together on a range of life science and biomedical research applications.

The Rochester, Minn.-based clinic and research center and India's Council of Scientific and Industrial Research (CSIR) have agreed to work together on biomarker, device, and drug studies related to genomics, chemical biology, metabolomics, heart disease, and other areas.

"We are engaging the best minds to help our research teams improve our fundamental understanding of disease and develop new, more effective therapies for our patients," Mayo Associate Dean for External Collaborations Eric Wieben said in a statement. "Strategic international research collaborations, such as this with the CSIR, India will help us achieve those goals."

CSIR Director General Samir Brahmachari said his council, which includes 39 national labs in India, and Mayo "share many strong interests in medical and technology research as well as health care delivery at affordable cost."

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.